This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Multifocal Motor Neuropathy
and you are
between 18 and 99
years old
The phase for this study is not defined.
Show me locations

The purpose

Subcutaneous immunoglobulin (SCIG) and recombinant human hyaluronidase (rHuPH20) will be tested in patient witch MMN and currently under maintenance treatment with IVIG for safety, tolerability and efficacy.

Provided treatments

  • Drug: rHuPH20

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02885259. The sponsor of the trial is UMC Utrecht and it is looking for 20 volunteers for the current phase.
Official trial title:
Subcutaneous Immunoglobulin With rHuPH20 in Multifocal Motor Neuropathy